Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search
Sign up for NAQC membership today!

Receive a monthly issue of Connections!
NAQC Newsroom: Tobacco Control

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review

Thursday, July 7, 2011  
Posted by: Natalia Gromov

1. Sonal Singh,

2. Yoon K. Loke,

3. John G. Spangler,

4. Curt D. Furberg

"There have been postmarketing reports of adverse cardiovascular events associated with the use of varenicline, a widely used smoking cessation drug. We conducted a systematic review and meta-analysis of randomized controlled trials to ascertain the serious adverse cardiovascular effects of varenicline compared with placebo among tobacco users."

View full article

Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 |